Clinical Trial Update: Study to Evaluate GSK2190915 in Subjects With Mild Asthma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating GSK2190915 in subjects with mild asthma has completed (sponsored by GlaxoSmithKline).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GSK2190915

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED